Drazba Brian G.
Insider CIK 1507369 · MEIP Chief Financial Officer · HRTX VP, Finance & CFO · ISTA VP, Finance & CAO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MEIP MEI Pharma, Inc. | A Award deriv | 2022-07-05 | 2022-07-07 | 350,000 | — | $0 | 350,000 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2021-07-01 | 2021-07-06 | 200,000 | — | $0 | 200,000 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2020-07-02 | 2020-07-07 | 230,000 | — | $0 | 230,000 | SEC↗ |
| MEIP MEI Pharma, Inc. | P Buy | 2019-12-19 | 2019-12-20 | 12,500 | $1.60 | $20.0K | 37,500 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2019-07-01 | 2019-07-03 | 230,000 | — | $0 | 230,000 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2018-07-12 | 2018-07-16 | 100,000 | — | $0 | 100,000 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2018-06-22 | 2018-06-26 | 130,000 | — | $0 | 130,000 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2017-07-06 | 2017-07-10 | 50,000 | — | $0 | 200,000 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2017-04-03 | 2017-04-04 | 150,000 | — | $0 | 150,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | J Other | 2016-10-31 | 2016-12-23 | 538 | $12.62 | $6.8K | 3,798 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | J Other | 2016-04-29 | 2016-12-23 | 577 | $18.22 | $10.5K | 3,260 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2015-12-22 | 2015-12-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | J Other | 2015-10-30 | 2015-12-24 | 714 | $9.36 | $6.7K | 2,683 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | J Other | 2015-04-30 | 2015-12-24 | 1,151 | $7.60 | $8.7K | 1,969 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2014-12-12 | 2014-12-15 | 35,000 | — | $0 | 35,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | J Other | 2014-10-31 | 2014-12-15 | 818 | $7.50 | $6.1K | 818 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | D To issuer deriv | 2012-06-06 | 2012-06-15 | 5,828 | — | $0 | 0 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | D To issuer deriv | 2012-06-06 | 2012-06-15 | 7,875 | — | $0 | 0 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | D To issuer deriv | 2012-06-06 | 2012-06-15 | 8,500 | — | $0 | 0 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | D To issuer deriv | 2012-06-06 | 2012-06-15 | 4,834 | — | $0 | 0 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | D To issuer deriv | 2012-06-06 | 2012-06-15 | 1,940 | — | $0 | 0 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | D To issuer deriv | 2012-06-06 | 2012-06-15 | 29,935 | — | $0 | 0 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | D To issuer | 2012-06-06 | 2012-06-15 | 40,487 | $9.10 | $368.4K | 0 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | M Exercise deriv | 2012-05-08 | 2012-05-10 | 7,492 | $9.08 | $68.0K | 5,828 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | M Exercise deriv | 2012-05-08 | 2012-05-10 | 19,125 | $9.08 | $173.7K | 7,875 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | M Exercise deriv | 2012-05-08 | 2012-05-10 | 2,416 | $9.08 | $21.9K | 4,834 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | M Exercise deriv | 2012-05-08 | 2012-05-10 | 4,250 | $9.08 | $38.6K | 584 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | M Exercise | 2012-05-08 | 2012-05-10 | 7,492 | $3.63 | $27.2K | 40,179 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | M Exercise | 2012-05-08 | 2012-05-10 | 4,250 | $4.58 | $19.5K | 42,631 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | M Exercise | 2012-05-08 | 2012-05-10 | 19,125 | $3.71 | $71.0K | 40,501 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | F Tax w/h | 2012-05-08 | 2012-05-10 | 7,814 | $9.08 | $71.0K | 32,687 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | F Tax w/h | 2012-05-08 | 2012-05-10 | 2,144 | $9.08 | $19.5K | 40,487 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | F Tax w/h | 2012-05-08 | 2012-05-10 | 2,995 | $9.08 | $27.2K | 37,184 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | M Exercise | 2012-05-08 | 2012-05-10 | 2,416 | $4.58 | $11.1K | 39,600 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | F Tax w/h | 2012-05-08 | 2012-05-10 | 1,219 | $9.08 | $11.1K | 38,381 | SEC↗ |